Loading…
Fierce Virtual Series: JPM Week 2021 has ended
TL

Trebor Lawton

Abyssinia Biologics, LLC
Co-Founder & CSO
Durham, NH
Trebor is Co-Founder and Chief Scientific Officer at Abyssinia Biologics where he leads the research and development efforts with academic collaborators. He is also responsible for developing and delivering on strategic decisions in connection with Abyssinia’s R&D and commercialization goals. Trebor received his degree in cellular and molecular biology from Connecticut College and has a demonstrated history in organizing the business and scientific components of research operations. An entrepreneur at heart, after graduation he designed and executed a publicly funded initiative to detect vector-borne disease biomarkers in patient samples collected at a state-wide level from MaineGeneral Health walk-in clinics. His experience expands beyond the decision-making room and into the wet lab where he has been involved in developing monoclonal antibodies to various fungal targets with Aliquot and Niche Diagnostics. Outside of work, Trebor leads an active lifestyle by surfing, skiing, hiking, and hunting.

Abyssinia Biologics is a preclinical-stage biotechnology company with a current focus on developing our Alzheimer's disease (AD) diagnostic and immunotherapeutic pipeline. Our monoclonal antibodies specifically target highly toxic, low molecular weight (LMW), oligomeric species of amyloid beta (Abeta), which is what differentiates our candidates from previous generations of anti-Abeta therapies, including the most recent Phase III failures. Our pipeline includes two monoclonal antibodies, 1G5 and 7A1a, in preclinical development for diagnostic and therapeutic use, and two peptide immunogens, ABY-043 and ABY-059, in early preclinical development as potential epitope vaccines. We are actively looking for partnership opportunities with companies in the CNS space dedicated to diagnosing, treating, and preventing Alzheimer’s disease.
  • Timezone
  • Filter By Date Fierce Virtual Series: JPM Week 2021 Jan 11 -13, 2021
  • Filter By Type
  • Interviews
  • Keynote
  • Networking
  • Panel Discussions
  • Presentations